In tumor-related studies, DDR2 is upregulated in a variety of cancer cells, and DDR2 is a major regulator of EMT, promoting the EMT process in cancers such as breast cancer (40, 41), liver cancer (28), and thyroid cancer (29). This evidence concerns the gene DDR2 and thyroid gland carcinoma.